SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 3 filers reported holding SAGE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,180 | +618.0% | 689 | +1540.5% | 0.00% | – |
| Q2 2023 | $1,975 | -24.1% | 42 | -32.3% | 0.00% | – |
| Q1 2023 | $2,602 | +62.4% | 62 | +47.6% | 0.00% | – |
| Q4 2022 | $1,602 | -46.6% | 42 | -37.3% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 67 | +168.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 25 | -57.6% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 59 | +110.7% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 28 | -53.3% | 0.00% | – |
| Q2 2021 | $3,000 | -40.0% | 60 | -13.0% | 0.00% | -100.0% |
| Q1 2021 | $5,000 | -28.6% | 69 | -14.8% | 0.00% | 0.0% |
| Q4 2020 | $7,000 | +75.0% | 81 | +22.7% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | +300.0% | 66 | +164.0% | 0.00% | – |
| Q2 2020 | $1,000 | -66.7% | 25 | -77.3% | 0.00% | -100.0% |
| Q1 2020 | $3,000 | – | 110 | +1471.4% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 7 | -96.0% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | -62.9% | 176 | -49.4% | 0.00% | -60.0% |
| Q2 2019 | $62,000 | +17.0% | 348 | 0.0% | 0.01% | +11.1% |
| Q1 2019 | $53,000 | – | 348 | +4871.4% | 0.01% | – |
| Q4 2018 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |